User profiles for Debra Zynger

Debra Zynger

The Ohio State University Medical Center
Verified email at osumc.edu
Cited by 3162

Chitosan-decorated doxorubicin-encapsulated nanoparticle targets and eliminates tumor reinitiating cancer stem-like cells

…, P Agarwal, W Zhang, G Zhao, J Yu, DL Zynger… - ACS …, 2015 - ACS Publications
Tumor reinitiating cancer stem-like cells are responsible for cancer recurrence associated
with conventional chemotherapy. We developed a doxorubicin-encapsulated polymeric …

The 2019 Genitourinary Pathology Society (GUPS) white paper on contemporary grading of prostate cancer

…, XJ Yang, M Zhou, DL Zynger… - … of pathology & …, 2021 - meridian.allenpress.com
Zynger, Kiril Trpkov; The 2019 Genitourinary Pathology Society (GUPS) White Paper on
Contemporary Grading of Prostate Cancer. Arch Pathol Lab Med 1 April 2021; 145 (4): 461–493…

Amide proton transfer MR imaging of prostate cancer: a preliminary study

…, R Abaza, JAD Williams, DL Zynger… - Journal of Magnetic …, 2011 - Wiley Online Library
Purpose: To evaluate the capability of amide proton transfer (APT) MR imaging for detection
of prostate cancer that typically shows a higher tumor cell proliferation rate and cellular …

Glypican 3: a novel marker in testicular germ cell tumors

DL Zynger, ND Dimov, C Luan, BT Teh… - The American journal of …, 2006 - journals.lww.com
Glypican 3 (GPC3), a membrane-bound heparin sulfate proteoglycan, may play a role in
promoting embryonic cell growth and differentiation. GPC3 is mutated in Simpson-Golabi-…

Definition of a FoxA1 Cistrome That Is Crucial for G1 to S-Phase Cell-Cycle Transit in Castration-Resistant Prostate Cancer

…, D Wu, H Chen, Z Chen, JM Thomas-Ahner, DL Zynger… - Cancer research, 2011 - AACR
The enhancer pioneer transcription factor FoxA1 is a global mediator of steroid receptor (SR)
action in hormone-dependent cancers. In castration-resistant prostate cancer (CRPC), …

Agonist and antagonist switch DNA motifs recognized by human androgen receptor in prostate cancer

…, B Sunkel, C Grenade, J Chen, DL Zynger… - The EMBO …, 2015 - embopress.org
Human transcription factors recognize specific DNA sequence motifs to regulate transcription.
It is unknown whether a single transcription factor is able to bind to distinctly different …

Enhanced enrichment of prostate cancer stem-like cells with miniaturized 3D culture in liquid core-hydrogel shell microcapsules

W Rao, S Zhao, J Yu, X Lu, DL Zynger, X He - Biomaterials, 2014 - Elsevier
Cancer stem-like cells (CSCs) are rare subpopulations of cancer cells that are reported to
be responsible for cancer resistance and metastasis associated with conventional cancer …

Performance comparison of 1.5-T endorectal coil MRI with 3.0-T nonendorectal coil MRI in patients with prostate cancer

ZK Shah, SN Elias, R Abaza, DL Zynger… - Academic radiology, 2015 - Elsevier
Rationale and Objectives To compare prostate morphology, image quality, and diagnostic
performance of 1.5-T endorectal coil magnetic resonance (MR) imaging (MRI) and 3.0-T …

Expression of glypican 3 in ovarian and extragonadal germ cell tumors

DL Zynger, MJ Everton, ND Dimov… - American journal of …, 2008 - academic.oup.com
Germ cell tumors (GCTs), rare malignancies that occur in a wide range of locations and
display variable histologic patterns, may pose diagnostic challenges. Glypican 3 (GPC3), a …

A combination of GATA3 and SOX10 is useful for the diagnosis of metastatic triple-negative breast cancer

GH Tozbikian, DL Zynger - Human pathology, 2019 - Elsevier
In metastatic breast cancer (MBC), it can be difficult to establish the origin if the primary tumor
is triple negative or if there is a loss of biomarker expression. SOX10 expression has been …